Issued Patents 2023
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11840571 | Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4 | Leslie S. Johnson, Gurunadh Reddy Chichili, Kalpana Shah, Ross La Motte-Mohs, Paul A. Moore +1 more | 2023-12-12 |
| 11820818 | Multi-chain polypeptide-containing tri-specific binding molecules | Leslie S. Johnson, Ling Huang, Gurunadh Reddy Chichili, Kalpana Shah, Chia-Ying Kao Lam +4 more | 2023-11-21 |
| 11697684 | Tri-specific binding molecules that specifically bind to multiple cancer antigens | Paul A. Moore, Jonathan Li, Leslie S. Johnson, Kalpana Shah | 2023-07-11 |
| 11685781 | Variant CD3-binding domains and their use in combination therapies for the treatment of disease | Ling Huang, Chia-Ying Kao Lam, Gurunadh Reddy Chichili, Ralph Alderson, Paul A. Moore +1 more | 2023-06-27 |
| 11639386 | Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof | Leslie S. Johnson, Chia-Ying Kao Lam, Paul A. Moore, Liqin Liu, Scott Koenig | 2023-05-02 |
| 11623959 | PD-1-binding molecules and methods of use thereof | Kalpana Shah, Douglas H. Smith, Ross La Motte-Mohs, Leslie S. Johnson, Paul A. Moore +1 more | 2023-04-11 |
| 11591400 | B7-H3 directed antibody drug conjugates | Deryk T. Loo, Ling Huang, Leslie S. Johnson, Thomas Son, Juniper A. Scribner | 2023-02-28 |